Menu
Back to Journals » Drug Design, Development and Therapy » Volume 11
Review
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,650 | Dovepress* | 12,500+ | 1,454 | 13,954 | |
| PubMed Central* | 1,150 | 505 | 1,655 | ||
| Totals | 13,650 | 1,959 | 15,609 | ||
| *Since 28 June 2017 | |||||
View citations on PubMed Central and Google Scholar